Page last updated: 2024-12-11

1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

The compound you're describing, **1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine**, is a complex organic molecule that has been the subject of research, but it's not a widely known or commonly studied compound.

Here's what we can glean from its structure:

* **Piperazine:** This is a six-membered ring containing two nitrogen atoms. Piperazine derivatives are often found in pharmaceuticals, particularly those targeting the central nervous system (CNS).
* **Diphenylmethoxy:** This group suggests the presence of a bulky, aromatic moiety.
* **3-Phenyl-2-propenyl:** This indicates a side chain with a phenyl ring and a double bond, potentially contributing to its biological activity.

**Importance in Research:**

Without specific research papers or context, it's difficult to determine the precise reasons for its importance. However, given its structural features, this compound could be of interest for the following reasons:

* **Potential pharmacological activity:** Its piperazine core and aromatic groups suggest it might interact with receptors or enzymes in the CNS, potentially exhibiting effects like:
* **Antidepressant or anti-anxiety properties:** Piperazines are frequently found in antidepressant and anti-anxiety drugs.
* **Antipsychotic effects:** Some piperazine derivatives have been investigated for their potential to treat psychosis.
* **Other CNS-related effects:** The compound could also possess analgesic, anticonvulsant, or other neuropharmacological activities.
* **Precursor for synthesis:** This compound could be a starting point for synthesizing novel derivatives with improved pharmacological properties or reduced side effects.
* **Structure-activity relationship studies:** Researchers might be interested in studying how the different parts of this molecule contribute to its overall biological activity.

**To find more detailed information about this compound, you would need to look for specific research papers or databases that focus on:**

* **Drug discovery and development:** Search for publications that list this compound as a potential drug candidate.
* **Pharmacology and toxicology:** Look for studies that have investigated the effects of this compound on living organisms.
* **Organic chemistry:** Search for literature that describes its synthesis and structural characterization.

Remember, without specific context or published research, it's impossible to definitively state the exact reasons for its importance.

1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine: dopamine uptake inhibitor and indirect dopamine agonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5788723
CHEMBL ID1612198
CHEBI ID92594
SCHEMBL ID2639562
MeSH IDM0118779

Synonyms (38)

Synonym
LS-15238
BRD-K34034388-300-01-0
BRD-K92015269-001-01-6
BPBIO1_001313
BIOMOL-NT_000055
NCGC00024627-02
piperazine, 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)-
gbr-12783
gbr 12783
1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine
gbr-12921
gbr 12921
1-(2-benzhydryloxyethyl)-4-[(e)-3-phenylprop-2-enyl]piperazine
lu 2-098
bdbm81954
cas_67469-75-4
1-(2-benzhydryloxy-ethyl)-4-((e)-3-phenyl-allyl)-piperazine dihydrochloride
67469-57-2
SCHEMBL2639562
gbr12783
CHEMBL1612198
CHEBI:92594
1-(2-(benzhydryloxy)ethyl)-4-cinnamylpiperazine
1-[2-(diphenyl-methoxy)ethyl]4-(3-phenyl-2-propenyl)piperazine
1-[2-(diphenylmethoxy)ethyl]-4-[(2e)-3-phenylprop-2-en-1-yl]piperazine
145428-33-7
DTXSID50860833
Q15634069
HY-W008610
CS-W009326
piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propen-1-yl)-
piperazine, 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)-, (e)-
piperazine, 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propen-1-yl)-
1-(2-(diphenylmethoxy)ethyl)-4-((2e)-3-phenylprop-2-en-1-yl)piperazine
piperazine, 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenyl-2-propenyl)-, (e)-
96y892tj2a ,
unii-96y892tj2a
AKOS040733233
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency35.48130.004023.8416100.0000AID485290
phosphopantetheinyl transferaseBacillus subtilisPotency56.23410.141337.9142100.0000AID1490
TDP1 proteinHomo sapiens (human)Potency4.13670.000811.382244.6684AID686978; AID686979
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency11.22020.035520.977089.1251AID504332
survival motor neuron protein isoform dHomo sapiens (human)Potency12.58930.125912.234435.4813AID1458
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (63)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (23.81)18.7374
1990's36 (57.14)18.2507
2000's6 (9.52)29.6817
2010's4 (6.35)24.3611
2020's2 (3.17)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.41 (24.57)
Research Supply Index4.17 (2.92)
Research Growth Index4.58 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other64 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]